J&J puts the brakes on immunotherapy combination studies – MedCity News
MedCity News |
J&J puts the brakes on immunotherapy combination studies
MedCity News The maker of a drug approved to treat the blood cancer multiple myeloma has stopped a clinical trial combining it with an immunotherapy agent in lung cancer and stopped another study in multiple myeloma. The decision came after a review committee found … |
